1)Rothwell S, Cooper RG, Lundberg IE, et al : Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups. Ann Rheum Dis 75:1558-1566,2016
2)Kochi Y, Kamatani Y, Kondo Y, et al : Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis. Ann Rheum Dis 77:602-611,2018
3)Christensen ML, Pachman LM, Schneiderman R, et al : Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis. Arthritis Rheum 29:1365-1370,1986
4)Sontheimer RD, Melissa I, Costner MI : Chapter 157. Wolff K, Goldsmith L, Katz S, et al(eds) : Fitzpatrick's Dermatology in General Medicine, 7th ed. McGraw-Hill, New York, pp1536-1552, 2008
5)冨滿弘之,太田晶子,上阪等:多発性筋炎/皮膚筋炎の疫学調査(2)—臨床調査個人票の解析から臨床疫学特性についての研究.厚生労働科学研究費補助金難治性疾患克服研究事業「自己免疫疾患に関する調査研究」.平成23年度総括・分担研究報告書,pp46-47,2012
6)Tomimitsu H, Ohta A, Nagai M, et al : Epidemiologic analysis of the clinical features of Japanese patients with polymyositis and dermatomyositis. Mod Rheumatol 26:398-402,2016
7)Sigurgeirsson B, Lindelöf B, Edhag O, et al : Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 326:363-367,1992
8)Kaji K, Fujimoto M, Hasegawa M, et al : Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis : an association with malignancy. Rheumatology (Oxford) 46:25-28,2007
9)Bohan A, Peter JB : Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344-347,1975
10)厚生労働省:50 皮膚筋炎/多発性筋炎,2015(https://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000089962.pdf)(2018年12月28日アクセス)
11)厚生労働科学研究費補助金難治性疾患政策研究事業自己免疫疾患に関する調査研究班多発性筋炎・皮膚筋炎分科会(編):多発性筋炎・皮膚筋炎治療ガイドライン.診断と治療社,2015